Skip to main content

House filed record · 2018

Periodic transaction report

Filed under Lamar Smith · House document 20010626

Structured rows
17
Filing year
2018
Record status
Transactions parsed
17 parsed transactions

Disclosures are reported transactions, not verified real-time portfolio holdings.

How to read this page

Use the House document as primary evidence and the rows below as a structured navigation aid.

What it can show

The filer, reported account owner, transaction and filing dates, asset label, and disclosed amount form.

What it cannot prove

Current holdings, cost basis, realized profit, investment intent, or misconduct.

Primary evidence

Original House filing

Document 20010626 is displayed from the House Clerk inside this research page. The structured rows below are our reading of the filed record, not a replacement for it.

Verify on House.gov ↗

The embedded document is served by the U.S. House Clerk. If your browser does not display PDFs inline, use “Verify on House.gov.”

Our structured reading

Reported transactions

Rows preserve the reported owner and filed amount form. Compare any row against the document above.

purchaseRep. Lamar SmithTX-21

HaRES oF PRaXaIR EXCHaNgEd FoR 56 SHaRES oF LINdE PLC. CoMMENTS: LINdE PLC CoMbINEd LINdE ag WITH PRaXaIR oN oCTobER 31,2018. aLL PRaXaIR SToCK EXCHaNgEd FoR LINdE PLC SToCK. (oNE SHaRE FoR oNE SHaRE). SToCK VaLUE IS CoST baSIS IN PRaXaIR. Portola Pharmaceuticals, Inc. (PTLa)

Rep. Lamar Smith disclosed that the filer purchased · $1,001 – $15,000

View transaction source status →
Traded Oct 3, 2018Notified Nov 7, 2018Filed Nov 8, 201836 days to file

Research journey

Continue researching

Put this document in context without treating one filing as a current portfolio or a conclusion about the filer.